Quantitating the Impact of Plerixafor
Phase 1
- Conditions
- Transplants and Implants
- Interventions
- First Posted Date
- 2015-08-13
- Last Posted Date
- 2020-06-30
- Lead Sponsor
- E. Steve Woodle
- Target Recruit Count
- 12
- Registration Number
- NCT02522572
- Locations
- ๐บ๐ธ
The Christ Hospital, Cincinnati, Ohio, United States
๐บ๐ธUniversity of Cincinnati, Cincinnati, Ohio, United States
Belimumab Impacting Transplant Eligibility
Phase 1
Completed
- Conditions
- Renal Transplant Rejection
- Interventions
- First Posted Date
- 2015-07-16
- Last Posted Date
- 2019-04-22
- Lead Sponsor
- E. Steve Woodle
- Target Recruit Count
- 11
- Registration Number
- NCT02500251
- Locations
- ๐บ๐ธ
University of Cincinnati, Cincinnati, Ohio, United States
๐บ๐ธThe Christ Hospital, Cincinnati, Ohio, United States
B-Cell Targeted Carfilzomib Desensitization
- First Posted Date
- 2015-05-13
- Last Posted Date
- 2020-06-30
- Lead Sponsor
- E. Steve Woodle
- Target Recruit Count
- 32
- Registration Number
- NCT02442648
- Locations
- ๐บ๐ธ
The Christ Hospital, Cincinnati, Ohio, United States
๐บ๐ธUniversity of Cincinnati, Cincinnati, Ohio, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath